OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s
Marek Wagner, Kafi N. Ealey, Hiroe Tetsu, et al.
Cell Reports (2020) Vol. 30, Iss. 8, pp. 2743-2757.e5
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
Lihua Chen, Lixiang Huang, Yu Gu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11943-11943
Open Access | Times Cited: 161

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Nicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 851-864
Open Access | Times Cited: 140

Innate lymphoid cells and cancer
Nicolas Jacquelot, Cyril Seillet, Éric Vivier, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 371-379
Open Access | Times Cited: 124

Emerging Functions of IL-33 in Homeostasis and Immunity
Gaelen K. Dwyer, Louise M. D’Cruz, Hēth Turnquist
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 15-43
Closed Access | Times Cited: 95

Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
Carl A. Shirley, Gagan Chhabra, Deeba Amiri, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16

Reinventing type 2 immunity in cancer
Marek Wagner, Hiroyoshi Nishikawa, Shigeo Koyasu
Nature (2025) Vol. 637, Iss. 8045, pp. 296-303
Closed Access | Times Cited: 3

Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression
Jingjing Qi, Adeline Crinier, Bertrand Escalière, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 8, pp. 100353-100353
Open Access | Times Cited: 79

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
Giuseppe Ercolano, Alejandra Gomez‐Cadena, Nina Dumauthioz, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67

Charge-reversal nanomedicines as a smart bullet for deep tumor penetration
Zimu Li, Yiwen Gao, Wen Li, et al.
Smart Materials in Medicine (2022) Vol. 3, pp. 243-253
Open Access | Times Cited: 65

The IL-1 family in tumorigenesis and antitumor immunity
Runzi Sun, David Shihong Gao, Jason Shoush, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 280-295
Open Access | Times Cited: 39

IL-33 biology in cancer: An update and future perspectives
Wen Jie Yeoh, Vivian Vu, Philippe Krebs
Cytokine (2022) Vol. 157, pp. 155961-155961
Open Access | Times Cited: 37

Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer
Fumimasa Kitamura, Takashi Semba, Noriko Yasuda‐Yoshihara, et al.
JCI Insight (2023) Vol. 8, Iss. 20
Open Access | Times Cited: 21

Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity
Jiawei Yue, Hui Guo, Peng Xu, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 4
Open Access | Times Cited: 6

Targeting the Epithelium-Derived Innate Cytokines: From Bench to Bedside
Jongho Ham, Jae Woo Shin, Byeong Cheol Ko, et al.
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 23

Knowledge mapping and research trends of IL-33 from 2004 to 2022: a bibliometric analysis
Jingyi Jin, Yantong Wan, Qiang Shu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14

Early Events Triggering the Initiation of a Type 2 Immune Response
Darine W. El-Naccache, György Haskó, William C. Gause
Trends in Immunology (2020) Vol. 42, Iss. 2, pp. 151-164
Open Access | Times Cited: 33

The crosstalking of lactate‐Histone lactylation and tumor
Yao Rong, Fengyuan Dong, Guiqian Zhang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2023) Vol. 17, Iss. 5
Closed Access | Times Cited: 12

Programmed cell death-1 receptor-mediated regulation of Tbet + NK1.1 innate lymphoid cells within the tumor microenvironment
Jing Xuan Lim, Chester Lai, Grace Mallett, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 11

Metabolic Dialogue Shapes Immune Response in the Tumor Microenvironment
Fengxia Gao, Rushil Shah, Gang Xin, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 4
Open Access

Decitabine co-operates with the IL-33/ST2 axis modifying the tumor microenvironment and improving the response to PD-1 blockade in melanoma
F. Noto, Jacopo Mancini, Adriana Rosa Gambardella, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight
Sara Andreone, Adriana Rosa Gambardella, Jacopo Mancini, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 31

Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity
Jinxin Qiu, Jingjing Zhang, Yanhui Ma, et al.
Mucosal Immunology (2021) Vol. 14, Iss. 6, pp. 1306-1322
Open Access | Times Cited: 25

Interleukin-33: A new frontier in cancer immunotherapy
Amrita Kaur, Kevin J. Bittorf, Ayan Chanda, et al.
International review of cell and molecular biology (2025)
Closed Access

The role of innate immune cells in modulating vascular dynamics in skin malignancies
Mateusz Marciniak, Martyna Stachowicz-Suhs, Marek Wagner
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189331-189331
Open Access

Page 1 - Next Page

Scroll to top